Public Employees Retirement Association of Colorado Acquires 175,060 Shares of Stryker Corporation $SYK

Public Employees Retirement Association of Colorado increased its holdings in Stryker Corporation (NYSE:SYK) by 401.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 218,695 shares of the medical technology company’s stock after purchasing an additional 175,060 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Stryker were worth $76,865,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Resources Management Corp CT ADV boosted its position in Stryker by 4,557.4% during the fourth quarter. Resources Management Corp CT ADV now owns 21,424 shares of the medical technology company’s stock valued at $7,530,000 after acquiring an additional 20,964 shares during the last quarter. Sargent Investment Group LLC bought a new stake in Stryker during the fourth quarter valued at $337,000. MML Investors Services LLC boosted its position in Stryker by 8.8% during the fourth quarter. MML Investors Services LLC now owns 55,527 shares of the medical technology company’s stock valued at $19,516,000 after acquiring an additional 4,514 shares during the last quarter. MayTech Global Investments LLC boosted its position in Stryker by 0.9% during the fourth quarter. MayTech Global Investments LLC now owns 48,135 shares of the medical technology company’s stock valued at $16,920,000 after acquiring an additional 434 shares during the last quarter. Finally, Mill Creek Capital Advisors LLC boosted its position in Stryker by 632.6% during the fourth quarter. Mill Creek Capital Advisors LLC now owns 4,410 shares of the medical technology company’s stock valued at $1,550,000 after acquiring an additional 3,808 shares during the last quarter. Institutional investors own 77.09% of the company’s stock.

Stryker Price Performance

SYK stock opened at $312.14 on Monday. The stock has a market capitalization of $119.66 billion, a PE ratio of 36.13, a price-to-earnings-growth ratio of 1.97 and a beta of 0.78. The company’s 50-day moving average is $316.40 and its 200-day moving average is $343.79. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.87.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.Stryker’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio is 40.74%.

Insider Transactions at Stryker

In other news, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the transaction, the vice president owned 10,582 shares of the company’s stock, valued at $3,247,298.34. This represents a 30.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP M Kathryn Fink sold 5,220 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the transaction, the vice president directly owned 13,137 shares in the company, valued at $3,728,937.45. This trade represents a 28.44% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 323,264 shares of company stock valued at $100,659,489 in the last 90 days. 4.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Truist Financial reaffirmed a “hold” rating and set a $330.00 price target (down from $380.00) on shares of Stryker in a research report on Monday, May 4th. William Blair reaffirmed an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Jefferies Financial Group reaffirmed a “buy” rating and set a $465.00 price target on shares of Stryker in a research report on Wednesday, March 4th. Finally, Wells Fargo & Company cut their price target on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $395.33.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.